The coexistence of RANKL+ T cells and OPG+ B cells within the tumor microenvironment suggests a functional balance between risk-promoting and protective lymphocyte subsets, offering a novel prognostic framework for stratifying patients based on their propensity to develop skeletal metastases. This evidence concerns the gene TNFSF11 and neoplasm.